Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
As flu season peaks, misconceptions about the flu vaccine continue to circulate and might prevent many from getting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback